Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Endocarditis I: Introduction

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Pericarditis I: Introduction

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.

International immunopharmacology·2020

Same author

Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.

European cytokine network·2018

Same author

Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.

Inflammopharmacology·2018

Same author

Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.

Immunopharmacology and immunotoxicology·2018

Same author

Human regulatory B cells control the T<sub>FH</sub> cell response.

The Journal of allergy and clinical immunology·2016

Same author

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.

Cellular & molecular immunology·2016

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Vasculitis: current status and future directions.

Pierre Youinou¹

¹Laboratory of Immunology, Brest University Medical School Hospital, Brest, France. youinou@univ-brest.fr

Clinical Reviews in Allergy & Immunology

|January 15, 2008

Summary

This summary is machine-generated.

Vasculitides are complex inflammatory disorders. New serological markers and targeted therapies, including B lymphocyte drugs, are improving classification and treatment alternatives.

Related Experiment Videos

Last Updated: Jul 8, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Area of Science:

Rheumatology
Immunology
Internal Medicine

Background:

Vasculitides encompass a diverse range of systemic inflammatory diseases affecting blood vessels.
Accurate classification of vasculitides presents challenges due to their heterogeneity.
Traditional diagnostic methods rely heavily on tissue biopsy.

Purpose of the Study:

To review advancements in the classification and management of vasculitides.
To highlight the role of emerging serological markers.
To discuss the potential of novel therapeutic strategies, particularly those targeting B lymphocytes.

Main Methods:

Review of current literature on vasculitis classification and diagnostics.
Analysis of recent developments in serological markers for vasculitis.
Evaluation of therapeutic strategies, including immunomodulatory agents.

Main Results:

New serological markers are enhancing diagnostic capabilities for vasculitides.
Therapeutic strategies are evolving, offering more targeted approaches.
B lymphocyte-targeted therapies show promise as effective treatment alternatives.

Conclusions:

Despite challenges in classification, advancements in diagnostics and therapeutics are improving patient outcomes.
Serological markers and targeted immunotherapies represent significant progress in managing vasculitides.